Calliditas Therapeutics
Develops novel treatments for rare diseases, focusing on renal and hepatic conditions like IgA nephropathy.
CALTX | ST
Overview
Corporate Details
- ISIN(s):
- SE0010441584 (+1 more)
- LEI:
- 549300PVPZO8TNT76B58
- Country:
- Sweden
- Address:
- Box 70351, 107 24 Stockholm
- Website:
- https://www.calliditas.se/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Calliditas Therapeutics is a commercial-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments for rare diseases, also known as orphan indications. The company leverages its scientific and commercial expertise to address significant unmet medical needs, with an initial focus on renal and hepatic diseases. Its flagship product, TARPEYO® (budesonide) delayed release capsules (marketed as Kinpeygo® in Europe), is the first treatment specifically developed and approved for IgA nephropathy. Calliditas is actively building its product pipeline and seeks strategic partnerships to advance the development and commercialization of new therapies for patients with limited treatment options.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Calliditas Therapeutics and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-09-16 15:30 |
Delisting Announcement
Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm
|
English | 134.8 KB | |
| 2024-09-16 15:30 |
Delisting Announcement
Avnotering av Calliditas Therapeutics AB (publ) från Nasdaq Stockholm
|
Swedish | 134.6 KB | |
| 2024-08-13 07:00 |
Interim Report
|
Swedish | 2.0 MB | |
| 2024-08-13 07:00 |
Interim Report
|
English | 2.0 MB | |
| 2024-08-06 11:00 |
Major Shareholding Notification
|
English | 34.7 KB | |
| 2024-08-05 13:51 |
Major Shareholding Notification
|
English | 34.5 KB | |
| 2024-07-31 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Calliditas Therapeutics
|
Swedish | 180.0 KB | |
| 2024-07-31 14:00 |
Share Issue/Capital Change
Number of shares and votes in Calliditas Therapeutics
|
English | 120.7 KB | |
| 2024-07-26 08:00 |
Earnings Release
Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliar…
|
English | 219.4 KB | |
| 2024-07-26 08:00 |
Regulatory News Service
Calliditas utläser positiva topline-data från fas 2b-studien TRANSFORM i primär…
|
Swedish | 223.3 KB | |
| 2024-06-17 17:30 |
Post-Annual General Meeting Information
Kommuniké från årsstämman i Calliditas Therapeutics AB (publ)
|
Swedish | 158.0 KB | |
| 2024-06-17 17:30 |
Post-Annual General Meeting Information
Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)
|
English | 141.0 KB | |
| 2024-06-04 10:15 |
Major Shareholding Notification
|
English | 34.1 KB | |
| 2024-05-30 20:00 |
Legal Proceedings Report
Calliditas partner STADA får positivt yttrande från CHMP som rekommenderar ett …
|
Swedish | 176.3 KB | |
| 2024-05-30 20:00 |
Legal Proceedings Report
Calliditas partner STADA receives positive CHMP opinion recommending full appro…
|
English | 177.8 KB |
Automate Your Workflow. Get a real-time feed of all Calliditas Therapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Calliditas Therapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-23 | Diane Parks | Other | Other | 4,086 | N/A |
| 2024-07-04 | Fredrik Johansson | Other | Sell | 36,000 | 7,408,800.00 SEK |
| 2024-07-04 | Fredrik Johansson | Other | Sell | 31,439 | 6,476,434.00 SEK |
| 2024-07-04 | Fredrik Johansson | Other | Buy | 40,939 | N/A |
| 2024-07-03 | Frank Bringstrup | Other | Sell | 8,000 | 1,646,400.00 SEK |
| 2024-07-02 | Richard Philipson | Other | Sell | 27,209 | 5,591,177.41 SEK |
| 2024-07-02 | Frank Bringstrup | Other | Sell | 9,796 | 2,012,980.04 SEK |
| 2024-07-02 | Sandra Boström Frithiof | Other | Sell | 6,530 | 1,341,849.70 SEK |
| 2024-07-01 | Richard Philipson | Other | Sell | 23,676 | 4,866,838.56 SEK |
| 2024-07-01 | Frank Bringstrup | Other | Sell | 8,523 | 1,751,987.88 SEK |
